SCHEMBL4909678

SCHEMBL4909678

CNC(=O)c1cccc2c(Nc3cc(C)cc(NC(=O)Oc4ccc(N(CCCl)CCCl)cc4)c3)c3cccc(C)c3nc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.35
EGFR P00533 2/20 0.35
ERBB2 P04626 2/20 0.35
TOP2A P11388 1/20 0.34
TOP2B Q02880 1/20 0.34
PIM1 P11309 3/20 0.33
PIM2 Q9P1W9 3/20 0.33
MAPT P10636 2/20 0.33
ABL1 P00519 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 2/20 0.32
PARP1 P09874 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
THRB P10828 1/20 0.32
GFER P55789 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909340 0.94 MTNR1A (0.36) KDM1AEGFRERBB2TOP2ATOP2B
SCHEMBL4937115 0.93 TOP2A (0.38) KDM1AEGFRERBB2TOP2ATOP2B
SCHEMBL4902918 0.93 KDM1A (0.36) KDM1AEGFRERBB2PIM1PIM2
SCHEMBL4938439 0.92 TOP2A (0.41) KDM1AEGFRERBB2TOP2ATOP2B
SCHEMBL4911335 0.90 RAD52 (0.42) KDM1AEGFRERBB2MAPTTP53
SCHEMBL4913281 0.90 KDM1A (0.40) KDM1AEGFRERBB2PIM1PIM2
SCHEMBL4910143 0.89 EGFR (0.40) KDM1AEGFRERBB2PIM1PIM2
SCHEMBL4914095 0.89 ABL1 (0.42) KDM1AEGFRERBB2PIM1PIM2
SCHEMBL4907520 0.89 ABL1 (0.39) KDM1AEGFRERBB2PIM1PIM2
SCHEMBL4915705 0.88 KDM1A (0.48) KDM1AEGFRERBB2TOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222297-B2 e.g. 1-[3-(acridin-9-ylamino)-5-hydroxymethylphenyl]-3-{4-[bis(2-chloroethyl)amino]phenyl}urea; anticarcinogenic agent; improved chemical stability and efficacy; brain tumor, breast cancer, colon cancer, leukemia, and neuroblastoma ACADEMIA SINICA (TW) 2012-07-17 US disclosed
US-20080171765-A1 Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents ACADEMIA SINICA (TW) 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171765-A1 Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents WEE1, PCNA, ATIC KDM1A 722/4885EGFR 896/4885ERBB2 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.